Pharmaceutical Trial Protocol: Study Title: Evaluation of Drug ABC in Treating Chronic Pain in Adult Patients. Phase: III. Objective: To confirm the efficacy and safety of Drug ABC for the treatment of chronic pain associated with osteoarthritis. Methodology: A multicentric, double-blind, randomized, placebo-controlled trial. Participants: 400 adults aged 40-75 with diagnosed osteoarthritis in the knees. Duration: 6 months. Outcome Measures: Primary outcome will be pain reduction as measured by the Visual Analog Scale (VAS). Secondary outcomes include improvement in mobility and quality of life scores. Safety assessments will include monitoring for adverse effects. The trial will adhere to GCP regulations and is registered at ClinicalTrials.gov.